10 results
Heart Failure with Reduced Ejection Fraction (HFrEF) - Guideline Directed Medical Therapy - Initiation Strategies

 •
Heart Failure with ... ACE, ARB, ARNI → Beta-Blocker ... low-dose approach: Beta-Blocker ... #management #GDMT ... #cardiology #titration
Heart Failure with Reduced Ejection Fraction (HFrEF) - Guideline Directed Medical Therapy
 • Beta-blocker
 • ACE,
Heart Failure with ... Ejection Fraction (HFrEF ... Medical Therapy • Beta-blocker ... #management #GDMT ... #cardiology
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Heart Failure (HFrEF ... and an evidenced beta-blocker ... tolerated ACEI/ARB + Beta-Blocker ... #HFrEF #Pharmacology ... #StageC #Cardiology
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-receptor blocker ... ; HFpEF, heart failure ... ejection fraction; HFrEF ... CHF #Congestive #HeartFailure ... #Cardiology
Severe Heart Failure & Cardiogenic Shock - Management Checklist 
Evaluation 
 - EKG & echocardiography
Cardiogenic Shock - Management ... Initiation of beta-blocker ... - Any beta-blocker ... #Cardiogenic #HeartFailure ... #Cardiology #Management
Beta Blockers - Pharmacology Comparison Table
Metoprolol:
 • Receptors: β1
 • Indications: Rate control of a-fib/a-flutter, Suppression
Beta Blockers - ... Pharmacology Comparison ... Post-MI, Heart failure ... #Blockers #Pharmacology ... #Receptors #cardiology
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
Chronic heart failure ... deficiency #CHF #HFrEF ... #heartfailure # ... diagnosis #management ... #cardiology
Target Doses in Congestive Heart Failure
 • Beta Blockers: Bisoprolol, Carvedilol, Metoprolol succinate, ARNI, Sacubitril/valsartan
 •
Congestive Heart Failure ... • Beta Blockers ... Doses #Congestive #HeartFailure ... #CHF #pharmacology ... #cardiology
Heart failure with Reduced Ejection Fraction (HFrEF)
Clinical Presentation
1. Typical symptoms: dyspnea, orthopnea paroxysmal noctumal dyspnea, fatigue,
Heart failure with ... inhibitors) • ß-Blockers ... #heartfailure # ... diagnosis #management ... #cardiology #pharmacology
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity
Anthracyclines cause cardiomyopathy:
 ✖ Reduction in left ventricular ejection fraction
Management of Anthracyclines ... inhibitor and beta-blocker ... blocker, or statin ... Cardiotoxicity #cardiology ... #oncology #pharmacology